Most AI medical device companies misunderstand PCCPs

A Predetermined Change Control Plan (PCCP) is not regulatory flexibility.

It is a pre-authorized change under strict control.

As FDA scrutiny increases.

Here’s what leaders need to know:

• A PCCP must clearly define which changes are allowed
• Statistical performance thresholds must be predefined
• Bias monitoring cannot be optional
• Drift detection must be built into governance
• Rollback procedures are mandatory
• Impact assessments must be documented for every update

If your PCCP is vague, FDA will issue deficiencies.

If your PCCP is overly narrow, you gain no flexibility.

The balance requires:

• AI governance maturity
• ISO 14971 integration
• Strong statistical design
• Regulatory foresight
• Cross-functional execution

Done correctly, a PCCP becomes a competitive advantage.

Done poorly, it increases regulatory risk.

AI innovation without a structured regulatory architecture is exposed.

At E&E Medicals & Consulting, we help manufacturers design FDA-ready PCCPs that scale globally and align with EU AI Act and MDR expectations.

If you're building AI-enabled devices, governance isn’t optional - it’s strategic.

— Dr. Ebot Eyong
Global AI Regulatory Strategy

For more information, visit https://eemedicals.com/